Mike Blankenship, managing partner of Winston & Strawn’s Houston office, returns to Vcheck Global’s podcast RiskWatch to discuss de-SPAC due diligence priorities, M&A sectors and regions to watch, and risks facing biotech and digital health investors. You can listen to our first conversation with Mike Blankenship on the RiskWatch podcast here.
This conversation covers:
- 00:42 – 01:45 Approaching De-SPAC deadlines
- 01:46 – 03:32 Reputational risk concerns when De-SPACing
- 03:33 – 04:41 Tips for target company due diligence
- 04:42 – 05:28 SPAC litigation patterns
- 05:29 -06:23 Inflation’s impact on tech investment
- 06:24 – 07:01 Sectors drawing SPAC attention
- 07:02 – 08:06 Conflict of interest concerns
- 08:07 – 11:15 ESG due diligence
- 11:16 – 12:04 M&A sectors and regions to watch
- 12:05 – 14:39 Theranos fraud due diligence failures
- 14:40 – 15:29 Interest in remote healthcare and telehealth solutions
RECENT EPISODES